Scottsdale Regional Healthcare Compliance Conference

The COVID-19 Vaccine: Which Populations Are and Should be Prioritized?

Will Humble, MPH Executive Director Arizona Public Health Association

• Become familiar with the FDA approval process for SARS CoV2 vaccines
• Understand the types of SARS CoV2 vaccines under development and production in the US
• Be able to identify the population groups that HHS has prioritized for initial vaccine administration and begin to critically think about the merits of their proposal

Presentation
Evaluation

OIG’s Self-Disclosure Protocol: Benefits, Eligibility, Requirements, and Resolution

Matthew J. Westbrook Senior Counsel OIG

• Learn the significant benefits to disclosing potential fraud
• Identify the who, what, where, when and why of SDP eligibility
• Know that an internal investigation and reporting of findings is required
• Understand how resolution is reached by cooperation, coordination, and reconciliation

Presentation
Evaluation

OIG Mandated Six-Year Look Back Audits

James Rose Managing Director SunHawk Consulting, LLC
Chad N. Eckhardt Attorney at Law Frost Brown Todd, LLC

• Use of statistical sampling and extrapolation
• Recent updates and perspectives
• Drivers of efficient and diligent analysis

Presentation
Handout 1
Handout 2
Handout 3
Evaluation

Compliance and Litigation Risks in the Wake of COVID-19

Frank Sheeder Partner Alston & Bird, LLP

• Key risk areas to address
• Preventive measures and Practical Approaches
• Lessons learned over 2020 and what to expect in 2021

Presentation
Evaluation

Advocacy in the Age of COVID

Debbie Johnston Executive Vice President Arizona Hospital and Healthcare Association
Elizabeth B. Lorenz Director of Policy Arizona Hospital and Healthcare Association

• Understand how public health emergency declarations impact lawmaking and the regulatory process
• List specific regulatory waivers and executive orders that have been issued during the COVID 19 emergency declaration, and apprehend how these were shaped by advocacy efforts
• Comprehend legal and regulatory issues that remain unsettled within the existing waiver and executive order framework

Presentation
Evaluation

Compliance Officer Effectiveness During a Pandemic – Never Let a Crisis Go to Waste

Cheyenne Ross Vice President, Compliance and Regulatory Affairs, Arizona Complete Health
David Murray Chief Compliance and Risk Management Officer, Summit Healthcare
Kimulet Winzer Director, SunHawk Consulting, LLC

• Identify the changes that are happening around you, what stakeholders are involved and how is that impacting your core compliance activity e.g. privacy and security, communicating with teams and stakeholders, and continuing work, systems and processes that support needs
• Identify steps to move forward e.g. assessment of risks, making adjustments to policies and procedures, keeping lines of communication open
• Leverage unexpected benefits e.g. generating creative solutions, increased engagement, interacting with new team members in a different way that promotes compliance and achieving business outcomes

Presentation
Evaluation